Product Description

The Devyser CFTR Next Generation Sequencing kit (NGS on Illumina MiSeq) is an in vitro diagnostic product intended for the detection of sequence variants in the CFTR gene in genomic DNA isolated from human tissue.


Cystic Fibrosis is an inherited disorder affecting children and young adults. Since the discovery of the CFTR gene in 1989 more than 2000 mutations and variants in the CFTR gene have been described. Mutations in the CFTR gene may cause respiratory disease. Other CFTR related disorders caused by CFTR dysfunction includes congenital bilateral absence of vas deferens (CBAVD), acute recurrent or chronic pancreatitis and disseminated bronchiectasis.

Product Details

Manufacturer Devyser
Unit 8 tests
Code 8-A101-8
For sale in GBR NIR IRL FRA
Launch Diagnostics is a licensed reseller and distributor of Devyser CFTR NGS

Launch Diagnostics is one of the major independent distributors in the U.K, providing high quality diagnostic reagents and instrumentation from world leading manufacturer’s to the Health Services of the United Kingdom, France, Belgium, Netherlands, Luxemburg and North Africa and to the Republic of Ireland through ACCUSAY Diagnostics.

Offering a large portfolio of diagnostic kits, laboratory instrumentation and services, our product range has expanded over the years to include a comprehensive range of EIA, single test devices, serology products, molecular assays and instrumentation.

GeneticsClinical Genetics